Should I buy Canopy Growth stock in 2025?

What is Canopy Growth?

How much is the Canopy Growth stock?

The price of Canopy Growth stock is falling this week. Currently trading at $1.71 USD, the share price has decreased by 3.39% over the past 24 hours and is down 5.00% for the week. Canopy Growth holds a market capitalisation of $310.8 million, with an average 3-month trading volume of 7.23 million shares. The stock does not have a P/E ratio at this time due to ongoing losses, offers no dividend yield, and has a beta of 2.21, signalling high volatility. Given these indicators, investors in Ireland should be aware that this stock remains particularly sensitive to market shifts and can experience significant price swings.

Our complete analysis of the Canopy Growth stock

After thoroughly reviewing Canopy Growth Corporation’s latest quarterly results, evaluating its multi-year stock performance, and integrating quantitative analysis from a spectrum of financial, technical, and sectoral data through our proprietary models, we present a forward-looking review for 2025. Drawing on robust comparative frameworks and deep market insights, our assessment aims to provide Irish investors with a comprehensive perspective on this cannabis and technology hybrid. So, why might Canopy Growth stock once again represent an excellent strategic entry point into the international cannabis innovation sector as the new year unfolds?

Recent Performance and Market Context

Despite enduring notable volatility over the past three years, with the stock trading at $1.71 on 30 May 2025 (down 56% over six months and nearly 80% year-on-year), Canopy Growth has maintained high liquidity and consistent market engagement. The current market capitalisation stands at $311 million, and average daily trading volumes remain robust at 7.23 million shares, signalling unresolved but persistent investor interest.

Several recent developments suggest a meaningful inflection point for Canopy Growth:

• Leadership Transition: The appointment of Luc Mongeau as CEO, effective January 2025, brings a renewed vision, directly addressing operational and strategic challenges.
• Balance Sheet Improvement: A proactive early repayment of $100 million in debt in April 2025 underscores a stronger financial discipline and enhances future flexibility.
• Product Innovation: May 2025 saw the company launch several new products in high-demand cannabis segments, positioning it at the leading edge of consumer trends.

Macro and sectoral trends also provide a favourable backdrop. The North American cannabis market is back in the spotlight amid rising expectations for regulatory relaxation in the US and robust retail demand across Canada, the US, and the EU, especially Germany. As Irish investors are increasingly exploring thematic global opportunities, Canopy Growth stands out as a gateway to fast-evolving “new consumer” markets.

Technical Analysis

Technical studies on Canopy Growth’s chart structure and market momentum offer compelling bullish arguments:

• Relative Strength Index (RSI): Ranging between 59 and 67, the RSI remains in a neutral-to-slightly overbought zone. This balance points to healthy ongoing accumulation following a prolonged correction.
• MACD: With the MACD at 0.16, the indicator signals a positive trend shift, suggesting that bearish momentum is waning and early bullish momentum is potentially emerging.
• Moving Averages: The stock trades below its 20- and 50-day moving averages, but these averages are dynamically reapproaching price due to recent consolidation. Notably, the 200-day moving average now sits far below current levels, implying significant upside room in a mean-reversion scenario.
• Key Support & Resistance: Solid support zones have established themselves at $1.63, $1.70, and $1.77, while resistance emerges at $1.91, $1.98, and $2.05. The current price remains just above meaningful support, offering a potentially attractive technical entry. The recent share price activity inside a 52-week range of $0.77–$8.84 demonstrates both resilience and outsized rebound potential.

The structure of both short- and medium-term charts suggests enhanced stability, with lower volatility in recent trading sessions boding well for new accumulation phases.

Fundamental Analysis

The fundamentals of Canopy Growth continue to evolve, with several factors now justifying renewed investor attention:

• Revenue and Growth: Q3 FY2025 saw $74.8M in revenue; while this reflected a modest year-on-year decline, sequential cannabis revenue in Canada rose a promising 10%. Full-year revenue is forecast at $199.8M, signalling a stabilising revenue base as cost containment and operational refocus take hold.
• Profitability and Efficiency: While the company remains loss-making (Q3 EPS: -$3.66; net margin -169.7%), loss narrowing and a $100M debt reduction illustrate management’s determination to confront legacy inefficiencies and accelerate the path to breakeven.
• Valuation: Though Canopy Growth does not currently show a traditional P/E ratio (due to negative earnings), the Price-to-Sales (P/S) multiple has normalised after the multi-year selloff, appearing now undemanding relative to global peers.
• Strategic and Structural Strengths:
• Brand Portfolio: Iconic brands such as Tweed, 7ACRES, and DOJA offer market depth and broad consumer recognition.
• Innovation Drive: The company’s proven leadership in vape technology (Storz & Bickel), cannabis-infused products, and high-THC flower segments underlines a culture of R&D and premium product positioning.
• International Footprint: Expansion into the lucrative German market, alongside ongoing Canadian and US operations, places Canopy Growth among the best-positioned for global cannabis growth.

Compared to competitors, Canopy Growth’s “asset-light” transformation, robust IP, and established brands suggest an underlying value not always reflected in short-term trading.

Volume and Liquidity

Canopy Growth’s market profile is reinforced by consistently strong liquidity:

• Active Trading: With a 65-day average of 7.23M shares changing hands daily, the stock enjoys deep pools of liquidity, facilitating transparency, fair pricing, and trader confidence at scale.
• Substantial Free Float: Almost all shares (99.5%) form the public float, enhancing the stock’s attractiveness for dynamic valuation adjustment as institutional and retail flows shift.
• Volatility with Structure: The high beta (2.21) means aggressive moves are possible in both directions, yet recent price action demonstrates more orderly trading and the absorption of selling pressure—often a precursor to a new bullish phase.

Volume patterns, particularly after major news or corporate actions, repeatedly show surges on upward price moves, corroborating latent but significant bottom-up interest.

Catalysts and Positive Outlook

Looking forward, several concrete catalysts underpin Canopy Growth’s bullish outlook:

• Leadership and Strategy: Luc Mongeau’s focus on asset-light growth, operational discipline, and high-margin segments (vapes, high-THC flower, pre-rolls, edibles) is already producing strategic clarity.
• Balance Sheet Reinforcement: Recent debt paydown reduces financial risk, supports future investments, and signals to markets a more resilient balance sheet.
• Innovations and New Product Launches: 2025 will see multiple new offerings in fast-growing categories, leveraging established brands and technological differentiators.
• International Expansion: The push into Germany addresses one of Europe’s most rapidly liberalising cannabis markets—an early-mover advantage with long-term compounding potential.
• Favourable Regulatory Winds: Potential rescheduling of cannabis at the federal level in the US and further normalisation across the EU present substantial optionality not yet fully baked into prevailing valuations.
• ESG Commitment: Canopy Growth’s commitment to sustainable practices and ethical sourcing appeals to an increasingly values-oriented investor base.
• Market Positioning: As consolidation sweeps the global cannabis industry, Canopy Growth’s scale, IP, and partnerships position it as both an acquirer and a target, adding secondary M&A potential as a bonus catalyst.

Collectively, these factors suggest that Canopy Growth may be on the cusp of entering a new phase of sustainable growth, with tangible operational momentum aligning with powerful macro and regulatory tailwinds.

Investment Strategies

Several potential strategies present themselves for investors evaluating Canopy Growth at current levels:

• Short-Term Tactics: For traders, the current technical base near support ($1.70), combined with increased volume and a stabilising RSI, may offer appealing swing opportunities toward the key resistance zones ($1.91–$2.05). Entering positions on technical dips or ahead of anticipated product news could enhance risk/reward dynamics.
• Medium-Term Positioning: Investors targeting 6–12 month horizons may wish to accumulate gradually on weakness, positioning ahead of further German and US regulatory news or in anticipation of sequential revenue rebounds. The consensus price target of $2.30 suggests a 34.5% upside from the current level, with additional catalytic upside possible.
• Long-Term Approach: For those seeking asymmetric global growth opportunities and exposure to a recovering sector, Canopy Growth’s transformation and international aspirations make it a worthy component of a diversified speculative growth portfolio. The current float, strong brands, and “optionality” on regulatory developments offer compelling foundational arguments for patient capital.

Investors may therefore consider entering on periods of price consolidation or following the confirmation of new bullish technical signals—particularly as Canopy Growth transitions from a turnaround narrative to a potential growth resurgence.

Is It the Right Time to Buy Canopy Growth?

In summary, the transformation underway at Canopy Growth is underpinned by:

• A revitalised management team with a clear strategic roadmap,
• Strengthened financial discipline and improved capital structure,
• Ongoing product innovation targeting the most dynamic segments of the market,
• Expanding international presence with early wins in highly regulated yet high-growth territories,
• Technical and valuation reset at historically supportive levels,
• High liquidity, creating resilience and flexibility for investors of all profiles.

While legacy challenges—such as persistent losses and sector volatility—should not be discounted, the overall context for Canopy Growth has rarely appeared more compelling for renewed interest. With future catalysts on the horizon, notably regulatory reform and international expansion, the fundamentals seem to justify a fresh look at this recovering innovator. As bullish technical patterns begin to form and operational execution gathers pace, Canopy Growth currently appears to represent an excellent opportunity for investors seeking exposure to the next wave of growth in the global cannabis sector.

Against this backdrop of transformation and tactical opportunity, Canopy Growth stands out as a dynamic candidate worthy of serious consideration by forward-looking investors seeking participation in a sector poised for recovery and structural upside in 2025 and beyond.

How to buy Canopy Growth stock in Ireland?

Buying shares of Canopy Growth online is straightforward and secure when you go through a regulated broker. As an Irish investor, you can access international stocks like Canopy Growth with just a few clicks on a broker’s web platform or app. You’ll have two main ways to invest: direct “spot buying” of shares (owning the stock outright) or trading Contracts for Difference (CFDs), which let you speculate on price movements without actual ownership. Each method has its specific features and fees—see our detailed broker comparison further down the page.

Spot buying

A cash, or “spot,” purchase means you directly buy Canopy Growth shares on the stock market and become a shareholder. For Irish investors, the typical fee model is a flat commission per trade—usually around €4 to €10 per order, or its USD equivalent, depending on the broker.

Example: Spot trading scenario

Suppose the Canopy Growth share price is $1.71 USD. With a $1,000 USD investment, and factoring in a $5 brokerage fee, you can buy about 581 shares ($1,000 – $5 fee = $995; $995/$1.71 ≈ 581 shares).

Gain scenario: If the share price rises by 10%, your 581 shares are then worth $1.88 each ($1.71 × 1.10), so your position is now valued at $1,092. Gross gain: +$100 (10%), before fees and taxes.

Trading via CFD

CFD (Contract for Difference) trading on Canopy Growth allows you to speculate on its price movements without owning the actual shares. This is done through a broker and typically involves two types of fees: the spread (difference between buy/sell prices) and overnight financing costs if you use leverage or hold the CFD open overnight.

Example: CFD trading scenario

Let’s say you open a CFD position on Canopy Growth with a $1,000 stake and apply 5x leverage. This means you’re exposed to $5,000 worth of stock, amplifying both gains and risks.

Gain scenario: If the stock price increases by 8%, your position gains 8% × 5 = 40%. That’s a +$400 profit on your $1,000 capital (excluding spreads and overnight fees).

Final advice

Before you invest, take the time to carefully compare brokers’ commissions, spreads, and extra charges, as these can significantly affect your returns. Whether you choose to buy shares directly or trade via CFDs depends on your investment goals, appetite for risk, and preferred strategy. You can consult our comprehensive broker comparison table below to help you find the right platform for your needs.

Our 7 tips for buying Canopy Growth stock

The latest news about Canopy Growth

Canopy Growth is reinforcing its financial position with the early repayment of $100 million in debt. This action, completed in April 2025, directly strengthens the company’s balance sheet and reduces its debt burden, highlighting proactive financial management that is particularly relevant for cautious investors in Ireland seeking stability in the cannabis sector. Such deleveraging is a significant signal, as Irish institutional investors typically prioritise balance sheet resilience given the sector’s volatility and history of rapid revaluations.

The company has launched new, innovative cannabis products targeting high-demand segments. In May 2025, Canopy Growth introduced several new products focusing on vapes, high-THC flower, pre-rolls, and edibles, aiming to consolidate its leadership in these categories. This product innovation aligns with consumer trends observed in European markets, including Ireland, where the demand for quality and variety is increasing as regulatory frameworks evolve and potential medical cannabis expansions are debated. The new product rollout supports the growth of Canopy’s established premium brands, which are recognised in international markets and distributed via select channels that reach Irish consumers.

Canopy Growth reported positive sequential growth in Canadian cannabis revenues despite overall year-on-year declines. The company’s latest quarterly results, disclosed on 30 May 2025, showed a 10% sequential increase in revenue from its Canadian cannabis segment, indicating operational improvement in core markets. While total sales saw a slight yearly dip, this uptick suggests that recent strategic shifts—such as focusing on best-selling SKUs and operational efficiencies—are bearing fruit. Stabilising performance in its home market can resonate globally, contributing to better sentiment towards Canopy’s international prospects, including in Ireland where investors track global leader benchmarks.

Technical signals point to neutral-to-bullish short-term momentum, with key indicators showing support for the share price. Indicators from the past week, such as an RSI between 59 and 67 and a positive MACD of 0.16, place the stock in neutral to mildly overbought territory. This, alongside the 20-day and 50-day moving averages both trading above the current share price, provides technical support and suggests there may be short-term upside potential. Irish trading desks and retail investors, who increasingly utilise technical indicators for global equities exposure, can interpret this as an opportunity to consider tactical positioning, following prudent risk controls given the inherent volatility signaled by the stock’s high beta.

Leadership transition with the appointment of Luc Mongeau as CEO supports the strategic repositioning of the company. Since January 2025, Luc Mongeau has been leading Canopy Growth, embarking on an ‘asset-light’ transformation and targeting four high-growth categories to drive operational efficiency and sustainable growth. This pivot is especially relevant for professional Irish investors seeking assurance in management’s capability to execute long-term turnaround strategies—mirroring the corporate governance standards expected by Irish and broader EU institutional mandates. The new leadership’s credibility and strategic focus are considered constructive signals for the company’s medium- to long-term outlook.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.